Treace Medical Concepts completed its initial public offering (IPO) in late April 2021, pricing its upsized offering at $17.00 per share. The company's common stock officially began trading on the Nasdaq Global Select Market under the ticker symbol "TMCI" on April 23, 2021, raising substantial gross proceeds to fund its commercial operations and research initiatives.